How much debt does GSK plc have?
According to GSK plc's latest annual financial reports, the company's debt profile is as follows:
Total Debt and Liabilities
GSK plc's total debt stands at $16.99B. This is broken down into:
- Long-term debt: $14.64B
- Short-term debt: $2.35B
The company's net debt, which accounts for cash and cash equivalents, is $13.29B. In terms of overall financial obligations, GSK plc's total liabilities amount to $46.38B.
Debt Ratios and Metrics
To better understand GSK plc's debt position, we can look at several key ratios:
- Debt to Equity Ratio: 1.24 - this indicates the proportion of equity and debt the company uses to finance its assets.
- Debt Ratio: 28.57% - this shows the proportion of a company's assets that are financed through debt.
- Interest Coverage Ratio: 6.28 - this measures how easily a company can pay interest on its outstanding debt.
- Long-term Debt to Capitalization: 50.06% - this shows the proportion of long-term debt in the company's capital structure.
- Total Debt to Capitalization: 55.41% - this indicates the total debt in the company's capital structure.
These metrics provide insight into GSK plc's financial leverage and its ability to meet financial obligations. For a comprehensive understanding of the company's financial health, it's important to consider these debt metrics alongside other financial indicators and industry benchmarks.
Total Debt
$16.99B
Long-term Debt
$14.64B
Short-term Debt
$2.35B
Net Debt
$13.29B
Total Liabilities
$46.38B
Interest Coverage
6.28
Debt to Equity Ratio
1.24
Debt Ratio
28.57%
GSK plc Historical Debt Metrics
GSK plc Historical Debt
The table below shows various debt metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Total Debt | Long-term Debt | Short-term Debt | Net Debt | Total Liabilities | Debt to Equity | Debt Ratio | Interest Coverage | Long-term Debt to Capitalization | Total Debt to Capitalization |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $16.99B | $14.64B | $2.35B | $13.29B | $46.38B | 1.24 | 28.57% | 6.28 | 50.06% | 55.41% |
| 2023 | $18.02B | $15.21B | $2.81B | $15.08B | $46.21B | 1.35 | 30.54% | 8.70 | 51.47% | 57.45% |
| 2022 | $20.99B | $17.04B | $3.95B | $17.26B | $50.05B | 1.98 | 34.89% | 7.32 | 60.44% | 66.45% |
| 2021 | $24.17B | $20.57B | $3.60B | $19.90B | $57.76B | 1.61 | 30.56% | 7.91 | 56.76% | 61.62% |
| 2020 | $27.15B | $23.43B | $3.73B | $20.86B | $59.62B | 1.86 | 33.76% | 8.73 | 60.71% | 65.05% |
| 2019 | $30.51B | $23.59B | $6.92B | $25.80B | $61.34B | 2.55 | 38.28% | 7.63 | 65.33% | 71.80% |
| 2018 | $26.06B | $20.27B | $5.79B | $22.19B | $54.39B | 5.98 | 44.89% | 6.87 | 82.27% | 85.67% |
| 2017 | $17.09B | $14.26B | $2.83B | $13.26B | $52.89B | -251.31 | 30.31% | 5.57 | 100.48% | 100.40% |
| 2016 | $18.79B | $14.66B | $4.13B | $13.89B | $54.12B | 16.72 | 31.80% | 3.53 | 92.86% | 94.36% |
| 2015 | $16.63B | $15.32B | $1.31B | $10.80B | $44.57B | 3.25 | 31.12% | 13.64 | 74.92% | 76.48% |
Related Metrics
Explore detailed financial metrics and analysis for GSK.L.